N&PD Moderators: Skorpio
You should upgrade or use an alternative browser.iodoamphetamine
serotonin2A
Bluelighter
I think you are discounting a huge body of scientific literature. It is well established that when mescaline binds to 5-HT2A, the 3- and 5-position methoxy groups form H-bonds with the receptor. Substituting non-H-bond accepting groups in the 3- and 5-positions is definitely known to reduce affinity.
http://pubs.acs.org/doi/abs/10.1021/jm060272ypr0d1gy
Bluelighter
In quite a few metal catalyzed cross coupling reactions aromatic iodides are very poor substrates, as are fluorides. Why this is the case with substrates like fluorobenzene is obvious. In the case of iodobenzenes the "softness" and size of the iodo substituent allow it to stabilize the metal involved in the redox reaction in its base oxidation state. P-fluoro makes it harder for the redox reaction that produces toxic products to react with the aromatic ring. Based on known in vitro chemistry, it's possible that the iodine molecule of p-iodoamphetamine stabilizes the metal active site in whatever enzyme catalyzes the conversion of p-haloamphetamines into toxic metabolites.
This type of chemistry occurs in some variations of the Ullmann Reaction. Maybe something similar is happening in the case of p-haloamphetamines. It seems like a plausible explanation for why p-iodo is less toxic than chloro or bromo.
Considering effects of 4-FMA and 4-FA, I guess I can imagine PCA and similar chloroamps to be MDMA-like for sure, but that can be true while going in 5-HT2A agonist directions similarities don't apply. It's not the same ballgame, despite MDMA-like tendencies that mescaline can have.adder
Bluelighter